Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.
作者信息
Commons Robert J, McCarthy James S, Price Ric N
机构信息
Menzies School of Health Research, Darwin, NT.
WorldWide Antimalarial Resistance Network, Darwin, NT.
出版信息
Med J Aust. 2020 Mar;212(4):152-153.e1. doi: 10.5694/mja2.50474. Epub 2020 Feb 9.
Abstract
摘要
相似文献
1
Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency.他非诺喹用于疟疾的根治和预防：检测葡萄糖-6-磷酸脱氢酶缺乏症的重要性
Med J Aust. 2020 Mar;212(4):152-153.e1. doi: 10.5694/mja2.50474. Epub 2020 Feb 9.
2
Tafenoquine and G6PD: a primer for clinicians.泰法诺喹与 G6PD：临床医生指南。
J Travel Med. 2019 Jun 1;26(4). doi: 10.1093/jtm/taz023.
3
Cost-Effectiveness Analysis of Sex-Stratified Treatment Strategies Using Available G6PD Diagnostics to Accelerate Access to Radical Cure.利用现有的 G6PD 诊断方法进行性别分层治疗策略的成本效益分析，以加速根治机会。
Am J Trop Med Hyg. 2020 Jul;103(1):394-403. doi: 10.4269/ajtmh.19-0943. Epub 2020 Apr 30.
4
Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries.使用伯氨喹和葡萄糖-6-磷酸脱氢酶缺乏症检测：疟疾流行国家的不同政策和做法。
PLoS Negl Trop Dis. 2018 Apr 19;12(4):e0006230. doi: 10.1371/journal.pntd.0006230. eCollection 2018 Apr.
5
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.泰非诺喹与伯氨喹预防间日疟复发。
N Engl J Med. 2019 Jan 17;380(3):229-241. doi: 10.1056/NEJMoa1802537.
6
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.他非诺喹用于预防间日疟原虫疟疾患者复发。
Cochrane Database Syst Rev. 2020 Sep 6;9(9):CD010458. doi: 10.1002/14651858.CD010458.pub3.
7
Hemolytic Potential of Tafenoquine in Female Volunteers Heterozygous for Glucose-6-Phosphate Dehydrogenase (G6PD) Deficiency ( Variant) versus G6PD-Normal Volunteers.他非诺喹对葡萄糖-6-磷酸脱氢酶（G6PD）缺乏（变异型）杂合子女性志愿者与G6PD正常志愿者的溶血潜力。
Am J Trop Med Hyg. 2017 Sep;97(3):702-711. doi: 10.4269/ajtmh.16-0779. Epub 2017 Jul 27.
8
Glucose-6-phosphate dehydrogenase deficiency and antimalarial drug development.葡萄糖-6-磷酸脱氢酶缺乏症与抗疟药物研发
Am J Trop Med Hyg. 2007 Oct;77(4):779-89.
9
Tafenoquine: a toxicity overview.他非喹：毒性概述。
Expert Opin Drug Saf. 2021 Mar;20(3):349-362. doi: 10.1080/14740338.2021.1859476. Epub 2021 Jan 4.
10
Approval of Tafenoquine for Malaria Chemoprophylaxis.特非那喹用于疟疾化学预防的批准。
Am J Trop Med Hyg. 2019 Jun;100(6):1301-1304. doi: 10.4269/ajtmh.19-0001.
引用本文的文献
1
Cethromycin pharmacokinetics and pharmacodynamics for single dose cure of liver stages.塞托霉素单剂量治愈肝期的药代动力学和药效学。
Antimicrob Agents Chemother. 2025 Jun 17:e0021525. doi: 10.1128/aac.00215-25.
2
Co-design of a routine clinical review to improve the safety of high dose radical cure treatment for Plasmodium vivax malaria: findings from Cambodia and Ethiopia.共同设计常规临床评估以提高间日疟原虫疟疾高剂量根治治疗的安全性：来自柬埔寨和埃塞俄比亚的研究结果
Malar J. 2025 May 28;24(1):171. doi: 10.1186/s12936-025-05425-3.
3
Integrated Phenotypic and Genotypic Approaches for Accurate Diagnosis of G6PD Deficiency: Implications for Drug Safety in Thailand.用于准确诊断葡萄糖-6-磷酸脱氢酶缺乏症的综合表型和基因型方法：对泰国药物安全性的影响
Pharmacol Res Perspect. 2025 Jun;13(3):e70117. doi: 10.1002/prp2.70117.
4
In vitro and in silico evaluation of synthetic compounds derived from bi-triazoles against asexual and sexual forms of Plasmodium falciparum.源自双三唑的合成化合物对恶性疟原虫无性和有性形式的体外及计算机模拟评估。
Malar J. 2025 Mar 4;24(1):74. doi: 10.1186/s12936-025-05297-7.
5
Cethromycin Pharmacokinetics and Pharmacodynamics for Single Dose Cure of Liver Stages.塞托霉素单剂量治愈肝脏期的药代动力学和药效学
bioRxiv. 2025 Feb 15:2025.02.10.637401. doi: 10.1101/2025.02.10.637401.
6
Exploring Appropriate Reference Intervals and Clinical Decision Limits for Glucose-6-Phosphate Dehydrogenase Activity in Individuals From Guangzhou, China.探讨中国广州个体葡萄糖-6-磷酸脱氢酶活性的适宜参考区间和临床决策限值。
Ann Lab Med. 2024 Nov 1;44(6):487-496. doi: 10.3343/alm.2023.0477. Epub 2024 May 3.
7
Field assessment of the operating procedures of a semi-quantitative G6PD Biosensor to improve repeatability of routine testing.现场评估半定量 G6PD 生物传感器的操作程序，以提高常规检测的重复性。
PLoS One. 2024 Jan 19;19(1):e0296708. doi: 10.1371/journal.pone.0296708. eCollection 2024.
8
Cytochrome P450 2D6 profiles and anti-relapse efficacy of tafenoquine against in Australian Defence Force personnel.细胞色素 P450 2D6 表型与泰法诺喹预防澳大利亚国防军人员疟疾复发的疗效。
Antimicrob Agents Chemother. 2023 Dec 14;67(12):e0101423. doi: 10.1128/aac.01014-23. Epub 2023 Nov 16.
9
Effect of adherence to primaquine on the risk of Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-analysis.遵循磷酸氯喹预防方案对降低间日疟复发风险的影响：世界疟疾耐药网络的系统评价和个体患者数据分析荟萃研究。
Malar J. 2023 Oct 10;22(1):306. doi: 10.1186/s12936-023-04725-w.
10
Population screening for glucose-6-phosphate dehydrogenase deficiency using quantitative point-of-care tests: a systematic review.使用即时定量检测法对葡萄糖-6-磷酸脱氢酶缺乏症进行人群筛查：一项系统评价
Front Genet. 2023 Jun 14;14:1098828. doi: 10.3389/fgene.2023.1098828. eCollection 2023.
本文引用的文献
1
Tafenoquine and G6PD: a primer for clinicians.泰法诺喹与 G6PD：临床医生指南。
J Travel Med. 2019 Jun 1;26(4). doi: 10.1093/jtm/taz023.
2
Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.泰非诺喹与伯氨喹预防间日疟复发。
N Engl J Med. 2019 Jan 17;380(3):229-241. doi: 10.1056/NEJMoa1802537.
3
Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.单次服用他非诺喹预防间日疟原虫疟疾复发。
N Engl J Med. 2019 Jan 17;380(3):215-228. doi: 10.1056/NEJMoa1710775.
4
Tafenoquine for travelers' malaria: evidence, rationale and recommendations. travellers’ malaria: evidence, rationale and recommendations.
J Travel Med. 2018 Jan 1;25(1). doi: 10.1093/jtm/tay110.
5
Evaluation of a Novel Quantitative Test for Glucose-6-Phosphate Dehydrogenase Deficiency: Bringing Quantitative Testing for Glucose-6-Phosphate Dehydrogenase Deficiency Closer to the Patient.新型葡萄糖-6-磷酸脱氢酶缺乏症定量检测的评估：使葡萄糖-6-磷酸脱氢酶缺乏症的定量检测更贴近患者。
Am J Trop Med Hyg. 2019 Jan;100(1):213-221. doi: 10.4269/ajtmh.18-0612.
6
Validation of the quantitative point-of-care CareStart biosensor for assessment of G6PD activity in venous blood.定量床旁 CareStart 生物传感器评估静脉血中 G6PD 活性的验证。
PLoS One. 2018 May 8;13(5):e0196716. doi: 10.1371/journal.pone.0196716. eCollection 2018.
7
Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.葡萄糖-6-磷酸脱氢酶（G6PD）缺乏症女性杂合子中伯氨喹所致溶血性贫血。
Malar J. 2018 Mar 2;17(1):101. doi: 10.1186/s12936-018-2248-y.
8
Methods for the field evaluation of quantitative G6PD diagnostics: a review.定量 G6PD 诊断的现场评估方法：综述。
Malar J. 2017 Sep 11;16(1):361. doi: 10.1186/s12936-017-2017-3.
9
Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study.泰非醌联合氯喹治疗和预防间日疟（DETECTIVE）：一项多中心、双盲、随机、2b 期剂量选择研究。
Lancet. 2014 Mar 22;383(9922):1049-58. doi: 10.1016/S0140-6736(13)62568-4. Epub 2013 Dec 19.
10
Primaquine toxicity forestalls effective therapeutic management of the endemic malarias.伯氨喹啉毒性妨碍了流行疟疾的有效治疗管理。
Int J Parasitol. 2012 Nov;42(12):1049-54. doi: 10.1016/j.ijpara.2012.06.006. Epub 2012 Aug 8.
Zotero 插件